Nano-composite scaffolds for bone tissue engineering containing silver nanoparticles: Preparation, characterization and biological properties

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 7, 2013, Pages 1799-1807

  Marsich, Eleonora ^a   Bellomo, Francesca ^a   Turco, Gianluca ^a   Travan, Andrea ^a   Donati, Ivan ^a   Paoletti, Sergio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL PROPERTIES; BACTERICIDAL EFFECTS; BIOLOGICAL PROPERTIES; BONE TISSUE ENGINEERING; COLLOIDAL SOLUTIONS; MICROCOMPUTED TOMOGRAPHY; SILVER NANOPARTICLES; TISSUE ENGINEERING APPLICATIONS;

ATOMIC EMISSION SPECTROSCOPY; BIOCOMPATIBILITY; BONE; COMPUTERIZED TOMOGRAPHY; GELATION; NANOCOMPOSITES; NANOPARTICLES; POROSITY; SCAFFOLDS; SCAFFOLDS (BIOLOGY);

SILVER;

ALGINIC ACID; CHITOSAN; HYDROXYAPATITE; LACTOSE; NANOCOMPOSITE; SILVER NANOPARTICLE; TISSUE SCAFFOLD;

ADSORPTION; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BACTERICIDAL ACTIVITY; BIOCOMPATIBILITY; BONE GRAFT; CELL PROLIFERATION; COLLOID; CONTROLLED STUDY; FREEZE DRYING; GELATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRO-COMPUTED TOMOGRAPHY; NANOFABRICATION; NONHUMAN; OSTEOSARCOMA CELL; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STATIC ELECTRICITY; TISSUE ENGINEERING; TUMOR CELL LINE;

ALGINATES; ANTI-BACTERIAL AGENTS; BONE AND BONES; CELL PROLIFERATION; DURAPATITE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MATERIALS TESTING; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; NANOCOMPOSITES; SILVER; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUMOR CELLS, CULTURED;

BACTERIA (MICROORGANISMS);

EID: 84879797685     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4923-4     Document Type: Article

References (33)

1. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-9.
2. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am. 1999;81(10):1434-45.
3. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol. 2011;77(5):1541-7.
4. Jaiswal S, McHale P, Duffy B. Preparation and rapid analysis of antibacterial silver, copper and zinc doped sol-gel surfaces. Colloids Surf B. 2012;94:170-6.
5. Stankovic A, Dimitrijevic S, Uskokovic D. Influence of size scale and morphology on antibacterial properties of ZnO powders hydrothemally synthesized using different surface stabilizing agents. Colloids Surf B. 2012;102C:21-8.
6. Wilkinson LJ, White RJ, Chipman JK. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. J Wound Care. 2011;20(11):543-9.
7. Lara HH, Garza-Trevino EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnol. 2011;9:30.
8. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2001;27(1):76-83.
9. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010;28(11):580-8.
10. Travan A, Marsich E, Donati I, Paoletti S. Silver nanocomposites and their biomedical applications. In: Kumar C, editor. nanocomposites. Wiley: New York; 2010. p. 81-137.
11. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25(18):4383-91.
12. Oei JD, Zhao WW, Chu L, Desilva MN, Ghimire A, Rawls HR, et al. Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B. 2011 [Epub ahead of print].
13. Travan A, Marsich E, Donati I, Benincasa M, Giazzon M, Felisari L, et al. Silver-polysaccharide nanocomposite antimicrobial coatings for methacrylic thermosets. Acta Biomater. 2011;7(1):337-46.
14. Yoshida K, Tanagawa M, Matsumoto S, Yamada T, Atsuta M. Antibacterial activity of resin composites with silver-containing materials. Eur J Oral Sci. 1999;107(4):290-6.
15. Tyllianakis M, Dalas E, Christofidou M, Kallitsis JK, Chrissanthopoulos A, Koutsoukos PG, et al. Novel composites materials from functionalized polymers and silver coated titanium oxide capable for calcium phosphate induction, control of orthopedic biofilm infections: an "in vitro" study. J Mater Sci Mater Med. 2010;21(7):2201-11.
16. Das K, Bose S, Bandyopadhyay A, Karandikar B, Gibbins BL. Surface coatings for improvement of bone cell materials and antimicrobial activities of Ti implants. J Biomed Mater Res B. 2008;87(2):455-60.
17. Saravanan S, Nethala S, Pattnaik S, Tripathi A, Moorthi A, Selvamurugan N. Preparation, characterization and antimicrobial activity of a bio-composite scaffold containing chitosan/nano-hydroxyapatite/nano-silver for bone tissue engineering. Int J Biol Macromol. 2011;49(2):188-93.
18. Turco G, Marsich E, Bellomo F, Semeraro S, Donati I, Brun F, et al. Alginate/hydroxyapatite biocomposite for bone ingrowth: a trabecular structure with high and isotropic connectivity. Biomacromolecules. 2009;10(6):1575-83.
19. Donati I, Stredanska S, Silvestrini G, Vetere A, Marcon P, Marsich E, et al. The aggregation of pig articular chondrocyte and synthesis of extracellular matrix by a lactose-modified chitosan. Biomaterials. 2005;26(9):987-98.
20. Travan A, Pelillo C, Donati I, Marsich E, Benincasa M, Scarpa T, et al. Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules. 2009;10(6):1429-35.
21. Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern. 1979;9(1):62-6.
22. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983;72(4):1396-409.
23. Wake MC, Patrick CW Jr, Mikos AG. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant. 1994;3(4):339-43.
24. Wang B, Chen K, Jiang S, Reincke F, Tong W, Wang D, et al. Chitosan-mediated synthesis of gold nanoparticles on patterned poly(dimethylsiloxane) surfaces. Biomacromolecules. 2006;7(4):1203-9.
25. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering.Part I. Tissue Eng. 2001;7:679-89.
26. Lubick N. Nanosilver toxicity: ions, nanoparticles-or both? Environ Sci Technol. 2008;42(23):8617.
27. Djordjevic VB. Free radicals in cell biology. Int Rev Cytol. 2004;237:57-89.
28. Gilca M, Stoian I, Atanasiu V, Virgolici B. The oxidative hypothesis of senescence. J Postgrad Med. 2007;53(3):207-13.
29. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415-8.
30. Koort JK, Makinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004;45(8):1406-11.
31. Arciola CR, Visai L, Testoni F, Arciola S, Campoccia D, Speziale P, et al. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues. Int J Artif Organs. 2011;34(9):771-80.
32. Montanaro L, Speziale P, Campoccia D, Ravaioli S, Cangini I, Pietrocola G, et al. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol. 2011;6(11):1329-49.
33. Uckay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med. 2009;41(2):109-19.